Dr. Benjamin Behroozan, MD

Dr. Behroozan practices at Great Care Medical Group in Los Angeles, California.

Dr. Behroozan's NPI, 1750440681, was assigned on December 6, 2006. Dr. Behroozan graduated from Ahvaz Jundishapur University of Medical Sciences in 1972. Dr. Behroozan holds California license A41374.

Dr. Behroozan's primary practice is Great Care Medical Group, at 5255 W Sunset Blvd, Los Angeles, CA 90027 in Los Angeles County. The practice phone is (323) 463-7262.

Dr. Behroozan's primary practice is Great Care Medical Group in Los Angeles, California. The medical group on file is Kids & Teens Medical Group. Dmand AI also links Dr. Behroozan to 1 more physician office, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Behroozan practices, 2 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Behroozan's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Behroozan is licensed in California.

Dmand AI lists acute skin infection, arthritis, chronic diabetes, chronic hypertension, cold sores or genital herpes, coronary artery disease, ear infection and enlarged prostate among the conditions Dr. Behroozan treats.

CMS data shows 58 Medicare services from Dr. Behroozan across 2 procedure codes in 2024, all of them office visits, for 44 Medicare patients. Medicare paid $3,216 for them. Every service was in an office.

CMS counts 44 Medicare patients who saw Dr. Behroozan in 2024. The largest group is 65 to 74, with 27 patients. 52% of them have high cholesterol, and 45% have high blood pressure. 75% are also on Medicaid. Their average risk score is 0.79, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Behroozan's median patient age at 37, with 57% women.

In 2024, Dr. Behroozan wrote 806 Medicare Part D claims for 130 patients. 87% of them were for generic drugs. CMS names the drug for 574 of them, across 20 drugs with 11 or more claims each, at $34,188 in total drug cost. In 2023, CMS named 665 claims across 20 drugs.

CMS Open Payments shows 13 general payments to Dr. Behroozan from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Cranial Technologies, Inc paid the most, $65.

Dr. Behroozan graduated from Ahvaz Jundishapur University of Medical Sciences in 1972.

Dr. Behroozan is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.